The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates

被引:69
作者
King, A [1 ]
Phillips, I [1 ]
机构
[1] KCL, Dept Infect, London SE1 7EH, England
关键词
D O I
10.1093/jac/48.2.219
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in vitro activity of daptomycin was assessed in comparison with that of vancomycin and penicillin against a wide range of Gram-positive aerobic clinical isolates. MICs were determined by an agar dilution method on Mueller-Hinton agar (NCCLS/EUCAST) and on Isotonic agar adjusted to contain 50 mg/L free calcium (BSAC). Both media were enriched with 5% horse blood for fastidious organisms. Daptomycin MICs for all 172 staphylococci, including methicillin-susceptible and methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis and Staphylococcus haemolyticus, were 0.03-0.5 mg/L. For 99 of the 100 enterococci (Enterococcus faecalis, n = 50; Enterococcus faecium, n = 50), including 37 vancomycin-resistant isolates, they were 0.25-2 mg/L. For all 108 beta -haemolytic streptococci, including Streptococcus pyogenes and Streptococcus agalactiae, daptomycin MICs were 0.016-0.25 mg/L; for 101 alpha -haemolytic streptococci, including Streptococcus pneumoniae and 'viridans' streptococci, they were 0.016-2 mg/L. For miscellaneous vancomycin-resistant isolates including Lactobacillus spp., Lactococcus spp., Leuconostoc spp., Pediococcus spp. and isolates of Enterococcus casseliflavus and Enterococcus gallinarum, daptomycin MICs were 0.03-2 mg/L; MICs for the seven isolates of Listeria monocytogenes were 0.25-4 mg/L. There was little difference between the results on Mueller-Hinton agar and on supplemented Isotonic agar The discrepant results occasionally obtained tended to be one dilution higher on supplemented Isotonic agar. Daptomycin was active (MICs less than or equal to 2 mg/L) against all the isolates tested with the exception of one isolate each of E. faecium and L. monocytogenes (MICs = 4 mg/L). Our results indicate that daptomycin MICs are independent of methicillin and vancomycin MICs.
引用
收藏
页码:219 / 223
页数:5
相关论文
共 14 条
  • [1] DAPTOMYCIN DISRUPTS MEMBRANE-POTENTIAL IN GROWING STAPHYLOCOCCUS-AUREUS
    ALBORN, WE
    ALLEN, NE
    PRESTON, DA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) : 2282 - 2287
  • [2] INHIBITION OF PEPTIDOGLYCAN BIOSYNTHESIS IN GRAM-POSITIVE BACTERIA BY LY146032
    ALLEN, NE
    HOBBS, JN
    ALBORN, WE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) : 1093 - 1099
  • [3] Determination of minimum inhibitory concentrations
    Andrews, JM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 : 5 - 16
  • [4] BSAC standardized disc susceptibility testing method
    Andrews, JM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 : 43 - 57
  • [5] LIPOTEICHOIC ACID AS A NEW TARGET FOR ACTIVITY OF ANTIBIOTICS - MODE OF ACTION OF DAPTOMYCIN (LY146032)
    CANEPARI, P
    BOARETTI, M
    LLEO, MD
    SATTA, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) : 1220 - 1226
  • [6] European Comm Antimicrobial Susc, 2000, CLIN MICROBIOL INFEC, V6, P509
  • [7] FUCHS PC, 1999, 39 INT C ANT AG CHEM, P199
  • [8] JACOBUS NV, 1998, 38 INT C ANT AG CHEM, P260
  • [9] DETECTION OF MECA, FEMA, AND FEMB GENES IN CLINICAL STRAINS OF STAPHYLOCOCCI USING POLYMERASE CHAIN-REACTION
    KOBAYASHI, N
    WU, H
    KOJIMA, K
    TANIGUCHI, K
    URASAWA, S
    UEHARA, N
    OMIZU, Y
    KISHI, Y
    YAGIHASHI, A
    KUROKAWA, I
    [J]. EPIDEMIOLOGY AND INFECTION, 1994, 113 (02) : 259 - 266
  • [10] TEICOPLANIN AND DAPTOMYCIN BACTERICIDAL ACTIVITIES IN THE PRESENCE OF ALBUMIN OR SERUM UNDER CONTROLLED CONDITIONS OF PH AND IONIZED CALCIUM
    LAMP, KC
    RYBAK, MJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) : 605 - 609